These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17651231)

  • 1. Venous leg ulcers - the search for a prognostic indicator.
    Moore K; Huddleston E; Stacey MC; Harding KG
    Int Wound J; 2007 Jun; 4(2):163-72. PubMed ID: 17651231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers.
    Harris IR; Yee KC; Walters CE; Cunliffe WJ; Kearney JN; Wood EJ; Ingham E
    Exp Dermatol; 1995 Dec; 4(6):342-9. PubMed ID: 8608341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activity as a prognostic factor for wound healing in venous leg ulcers.
    Westby MJ; Dumville JC; Stubbs N; Norman G; Wong JK; Cullum N; Riley RD
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012841. PubMed ID: 30171767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of markers of collagen remodeling in venous ulcers.
    Tarlton JF; Bailey AJ; Crawford E; Jones D; Moore K; Harding KD
    Wound Repair Regen; 1999; 7(5):347-55. PubMed ID: 10564563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
    Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
    Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of Skin Graft Healing in Venous Leg Ulcers.
    Kirketerp-Møller K; Doerfler P; Schoefmann N; Wolff-Winiski B; Niazi O; Pless V; Karlsmark T; Ågren MS
    Acta Derm Venereol; 2022 Jul; 102():adv00749. PubMed ID: 35604238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine.
    Mannello F; Ligi D; Canale M; Raffetto JD
    Expert Rev Mol Diagn; 2014 Jul; 14(6):737-62. PubMed ID: 24918119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate endpoints for the treatment of venous leg ulcers.
    Gelfand JM; Hoffstad O; Margolis DJ
    J Invest Dermatol; 2002 Dec; 119(6):1420-5. PubMed ID: 12485449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Evaluation of Biomarkers in Wound Fluids from Venous Leg Ulcers and Split-thickness Skin Graft Donor Site Wounds Treated with a Protease-modulating Wound Dressing.
    Mikosiński J; Kalogeropoulos K; Bundgaard L; Larsen CA; Savickas S; Moldt Haack A; Pańczak K; Rybołowicz K; Grzela T; Olszewski M; Ciszewski P; Sitek-Ziółkowska K; Twardowska-Saucha K; Karczewski M; Rabczenko D; Segiet A; Buczak-Kula P; Schoof EM; Eming SA; Smola H; Auf dem Keller U
    Acta Derm Venereol; 2022 Dec; 102():adv00834. PubMed ID: 36250733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does noncontact low-frequency ultrasound therapy contribute to wound healing at the molecular level?
    Wiegand C; Bittenger K; Galiano RD; Driver VR; Gibbons GW
    Wound Repair Regen; 2017 Sep; 25(5):871-882. PubMed ID: 29098740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in chronic venous ulcers.
    Raffetto JD
    Phlebology; 2013 Mar; 28 Suppl 1():61-7. PubMed ID: 23482537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for delayed healing in venous leg ulcers: a review of the literature.
    Parker CN; Finlayson KJ; Shuter P; Edwards HE
    Int J Clin Pract; 2015 Sep; 69(9):967-77. PubMed ID: 25831965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
    Wallace HJ; Stacey MC
    J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-modulating matrix treatments for healing venous leg ulcers.
    Westby MJ; Norman G; Dumville JC; Stubbs N; Cullum N
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011918. PubMed ID: 27977053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.
    Serra R; Grande R; Buffone G; Molinari V; Perri P; Perri A; Amato B; Colosimo M; de Franciscis S
    Int Wound J; 2016 Feb; 13(1):53-8. PubMed ID: 24618232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic venous leg ulcers: is topical zinc the answer? A review of the literature.
    O'Connor S; Murphy S
    Adv Skin Wound Care; 2014 Jan; 27(1):35-44; quiz 45-6. PubMed ID: 24343392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gene signature of nonhealing venous ulcers: potential diagnostic markers.
    Charles CA; Tomic-Canic M; Vincek V; Nassiri M; Stojadinovic O; Eaglstein WH; Kirsner RS
    J Am Acad Dermatol; 2008 Nov; 59(5):758-71. PubMed ID: 18718692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of proteases as prognostic markers for the healing of venous leg ulcers.
    Hoffman R; Noble J; Eagle M
    J Wound Care; 1999 Jun; 8(6):273-6. PubMed ID: 10776209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.